Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) SHH

17.50

+0.74(+4.42%)

Updated at February 13 03:00PM

Currency In CNY

Jiangsu Aidea Pharmaceutical Co., Ltd.

Address

No. 2 Liuzhuang Road

Yangzhou, 225008

China

Phone

86 514 8753 0666

Sector

Healthcare

Industry

Biotechnology

Employees

476

First IPO Date

July 20, 2020

Key Executives

NameTitlePayYear Born
Jie ZhangChief Executive Officer, President & Director01970
Gaohong GuSenior Vice President01967
Hong QinVice President01980
Jibing ZhangFactory Manager of Human Protein01966
Qide LiDirector of Pharmaceutical Research Institute01980
Tie SunDirector of Pharmacology and Toxicology and Senior Director of Biologics R&D01978
Yu YuanQuality Center Director01979
Chuanhong ZhuFinancial Director & Accounting Supervisor01972
Guang Rong WangVP & Director01977
Yan LiuSecretary of the Board01982

Description

Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules, as well as raw materials. The company was founded in 2009 and is based in Yangzhou, China.